ARTICLE | Company News
Zenyth, MuriGen antibody deal
February 22, 2006 2:23 AM UTC
Zenyth (ASX:ZTL) and MuriGen (Victoria, Australia) will research and develop therapeutic proteins that inhibit G-CSF or its receptor to treat arthritis and other inflammatory diseases. The deal combin...